Application of methylene blue -vitamin C –N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial()

COVID-19 is a global catastrophic event that causes severe acute respiratory syndrome. The mechanism of the disease remains unclear, and hypoxia is one of the main complications. There is no currently approved protocol for treatment. The microbial threat as induced by COVID-19 causes the activation...

Full description

Saved in:
Bibliographic Details
Published in:Eur J Pharmacol
Main Authors: Alamdari, Daryoush Hamidi, Moghaddam, Ahmad Bagheri, Amini, Shahram, Keramati, Mohammad Reza, Zarmehri, Azam Moradi, Alamdari, Aida Hamidi, Damsaz, Mohammadamin, Banpour, Hamed, Yarahmadi, Amir, Koliakos, George
Format: Artigo
Language:Inglês
Published: Elsevier B.V. 2020
Subjects:
Full Length Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7440159/
https://ncbi.nlm.nih.gov/pubmed/32828741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2020.173494
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items